Report Detail
Global Ophthalmic Drugs Market Professional Survey Report 2019
- RnM3742019 |
- 12 September, 2019 |
- Global |
- 115 Pages |
- QYResearch |
- Pharma & Healthcare
Ophthalmic drugs are extensively used to treat glaucoma, cataract, diabetic retinopathy, and other ophthalmic disorders. Introduction of novel ocular drug delivery approaches in the market has driven the manufacturers to develop innovative therapeutic approaches for the treatment of ophthalmic disorders.
The other key factors that boost the ophthalmic drug market size include high prevalence of glaucoma worldwide and rise in transition towards development of combination therapies for the treatment of glaucoma.
According to the American Academy of Ophthalmology over 27.1 million of North American population is suffering from Primary Open Angle Glaucoma (POAG) and this number is constantly rising. Thus, increasing eye disorders is fueling the growth of the global ophthalmic drugs market.
It was reported that around two-third of the population in the Asia Pacific region are blind or vision impaired. Moreover, development of various novel technologies in developing markets such as China & India is expected to improve healthcare facilities.
The global Ophthalmic Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Ophthalmic Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Ophthalmic Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Ophthalmic Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Ophthalmic Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Santen Pharmaceutical
Valeant Pharmaceuticals
Shire
Novartis
Genentech
Allergan
Sun Pharmaceutical Industries
Actavis Generics
Regeneron Pharmaceuticals
Pfizer
Johnson and Johnson
Bausch and Lomb
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
By Class
Anti-allergy
Anti-VEGF Agents
Anti-inflammatory
Anti-glaucoma
By Disease
Dry Eye
Allergies
Glaucoma
Infection
Retinal Disorders
Uveitis
Segment by Application
Hospital
Clinic
Pharmacy
Table of Contents
Executive Summary
1 Industry Overview of Ophthalmic Drugs
- 1.1 Definition of Ophthalmic Drugs
- 1.2 Ophthalmic Drugs Segment By Class
- 1.2.1 Global Ophthalmic Drugs Production Growth Rate Comparison By Class (2014-2025)
- 1.2.2 Anti-allergy
- 1.2.3 Anti-VEGF Agents
- 1.2.4 Anti-inflammatory
- 1.2.5 Anti-glaucoma
- 1.3 Ophthalmic Drugs Segment by Applications
- 1.3.1 Global Ophthalmic Drugs Consumption Comparison by Applications (2014-2025)
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.3.4 Pharmacy
- 1.4 Global Ophthalmic Drugs Overall Market
- 1.4.1 Global Ophthalmic Drugs Revenue (2014-2025)
- 1.4.2 Global Ophthalmic Drugs Production (2014-2025)
- 1.4.3 North America Ophthalmic Drugs Status and Prospect (2014-2025)
- 1.4.4 Europe Ophthalmic Drugs Status and Prospect (2014-2025)
- 1.4.5 China Ophthalmic Drugs Status and Prospect (2014-2025)
- 1.4.6 Japan Ophthalmic Drugs Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Ophthalmic Drugs Status and Prospect (2014-2025)
- 1.4.8 India Ophthalmic Drugs Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Ophthalmic Drugs
- 2.3 Manufacturing Process Analysis of Ophthalmic Drugs
- 2.4 Industry Chain Structure of Ophthalmic Drugs
3 Development and Manufacturing Plants Analysis of Ophthalmic Drugs
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Ophthalmic Drugs Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Ophthalmic Drugs
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Ophthalmic Drugs Production and Capacity Analysis
- 4.2 Ophthalmic Drugs Revenue Analysis
- 4.3 Ophthalmic Drugs Price Analysis
- 4.4 Market Concentration Degree
5 Ophthalmic Drugs Regional Market Analysis
- 5.1 Ophthalmic Drugs Production by Regions
- 5.1.1 Global Ophthalmic Drugs Production by Regions
- 5.1.2 Global Ophthalmic Drugs Revenue by Regions
- 5.2 Ophthalmic Drugs Consumption by Regions
- 5.3 North America Ophthalmic Drugs Market Analysis
- 5.3.1 North America Ophthalmic Drugs Production
- 5.3.2 North America Ophthalmic Drugs Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Ophthalmic Drugs Import and Export
- 5.4 Europe Ophthalmic Drugs Market Analysis
- 5.4.1 Europe Ophthalmic Drugs Production
- 5.4.2 Europe Ophthalmic Drugs Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Ophthalmic Drugs Import and Export
- 5.5 China Ophthalmic Drugs Market Analysis
- 5.5.1 China Ophthalmic Drugs Production
- 5.5.2 China Ophthalmic Drugs Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Ophthalmic Drugs Import and Export
- 5.6 Japan Ophthalmic Drugs Market Analysis
- 5.6.1 Japan Ophthalmic Drugs Production
- 5.6.2 Japan Ophthalmic Drugs Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Ophthalmic Drugs Import and Export
- 5.7 Southeast Asia Ophthalmic Drugs Market Analysis
- 5.7.1 Southeast Asia Ophthalmic Drugs Production
- 5.7.2 Southeast Asia Ophthalmic Drugs Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Ophthalmic Drugs Import and Export
- 5.8 India Ophthalmic Drugs Market Analysis
- 5.8.1 India Ophthalmic Drugs Production
- 5.8.2 India Ophthalmic Drugs Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Ophthalmic Drugs Import and Export
6 Ophthalmic Drugs Segment Market Analysis (by Type)
- 6.1 Global Ophthalmic Drugs Production by Type
- 6.2 Global Ophthalmic Drugs Revenue by Type
- 6.3 Ophthalmic Drugs Price by Type
7 Ophthalmic Drugs Segment Market Analysis (by Application)
- 7.1 Global Ophthalmic Drugs Consumption by Application
- 7.2 Global Ophthalmic Drugs Consumption Market Share by Application (2014-2019)
8 Ophthalmic Drugs Major Manufacturers Analysis
- 8.1 Santen Pharmaceutical
- 8.1.1 Santen Pharmaceutical Ophthalmic Drugs Production Sites and Area Served
- 8.1.2 Santen Pharmaceutical Product Introduction, Application and Specification
- 8.1.3 Santen Pharmaceutical Ophthalmic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Valeant Pharmaceuticals
- 8.2.1 Valeant Pharmaceuticals Ophthalmic Drugs Production Sites and Area Served
- 8.2.2 Valeant Pharmaceuticals Product Introduction, Application and Specification
- 8.2.3 Valeant Pharmaceuticals Ophthalmic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Shire
- 8.3.1 Shire Ophthalmic Drugs Production Sites and Area Served
- 8.3.2 Shire Product Introduction, Application and Specification
- 8.3.3 Shire Ophthalmic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Novartis
- 8.4.1 Novartis Ophthalmic Drugs Production Sites and Area Served
- 8.4.2 Novartis Product Introduction, Application and Specification
- 8.4.3 Novartis Ophthalmic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Genentech
- 8.5.1 Genentech Ophthalmic Drugs Production Sites and Area Served
- 8.5.2 Genentech Product Introduction, Application and Specification
- 8.5.3 Genentech Ophthalmic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Allergan
- 8.6.1 Allergan Ophthalmic Drugs Production Sites and Area Served
- 8.6.2 Allergan Product Introduction, Application and Specification
- 8.6.3 Allergan Ophthalmic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Sun Pharmaceutical Industries
- 8.7.1 Sun Pharmaceutical Industries Ophthalmic Drugs Production Sites and Area Served
- 8.7.2 Sun Pharmaceutical Industries Product Introduction, Application and Specification
- 8.7.3 Sun Pharmaceutical Industries Ophthalmic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Actavis Generics
- 8.8.1 Actavis Generics Ophthalmic Drugs Production Sites and Area Served
- 8.8.2 Actavis Generics Product Introduction, Application and Specification
- 8.8.3 Actavis Generics Ophthalmic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Regeneron Pharmaceuticals
- 8.9.1 Regeneron Pharmaceuticals Ophthalmic Drugs Production Sites and Area Served
- 8.9.2 Regeneron Pharmaceuticals Product Introduction, Application and Specification
- 8.9.3 Regeneron Pharmaceuticals Ophthalmic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Pfizer
- 8.10.1 Pfizer Ophthalmic Drugs Production Sites and Area Served
- 8.10.2 Pfizer Product Introduction, Application and Specification
- 8.10.3 Pfizer Ophthalmic Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
- 8.11 Johnson and Johnson
- 8.12 Bausch and Lomb
9 Development Trend of Analysis of Ophthalmic Drugs Market
- 9.1 Global Ophthalmic Drugs Market Trend Analysis
- 9.1.1 Global Ophthalmic Drugs Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Ophthalmic Drugs Regional Market Trend
- 9.2.1 North America Ophthalmic Drugs Forecast 2019-2025
- 9.2.2 Europe Ophthalmic Drugs Forecast 2019-2025
- 9.2.3 China Ophthalmic Drugs Forecast 2019-2025
- 9.2.4 Japan Ophthalmic Drugs Forecast 2019-2025
- 9.2.5 Southeast Asia Ophthalmic Drugs Forecast 2019-2025
- 9.2.6 India Ophthalmic Drugs Forecast 2019-2025
- 9.3 Ophthalmic Drugs Market Trend (Product Type)
- 9.4 Ophthalmic Drugs Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Ophthalmic Drugs Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Ophthalmic Drugs. Industry analysis & Market Report on Ophthalmic Drugs is a syndicated market report, published as Global Ophthalmic Drugs Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Ophthalmic Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
